Share on LinkedInShare on LinkedIn

ARTICLE · 15 JUNE 2013

Pharmaceutical trade marks case law round up for 2012/early 2013

Corrs Chambers Westgarth
Corrs Chambers Westgarth
Contributor
Corrs Chambers Westgarth

Corrs Chambers Westgarth

Corrs Chambers Westgarth is Australia’s leading independent law firm. We provide exceptional legal...

View firm profile
Explore more from Corrs Chambers Westgarth

This is a brief wrap-up of recent decisions relating to pharma trade marks from the EU, the United States and Australia.

AustraliaIntellectual Property

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia.

If you would like a copy of the presentation given in Hamburg, please contact the author.

At the recent Pharmaceutical Trade Marks Group conference in Hamburg I was invited to provide a global case law round-up, taking in important decisions relating to trade marks in the pharma space from the EU, the United States and Australia.

  • There was an enormous amount of material to get through, but the main topics related to formalities (and particularly cases since IP Translator and OHIM's President's Communication 2/2012, such as the General Court's decision in Present-Service Ullrich GmbH & Co. KG v OHIM (31 January 2013)), absolute grounds, relative grounds and non-use.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from